Skip to content

Intervention Study of Probiotic Supplementation on Subclinical Cardiovascular Impairment in Night-Shift Designated Drivers within Emerging Employment Sectors

Intervention Study of Probiotic Supplementation on Subclinical Cardiovascular Impairment in Night-Shift Designated Drivers within Emerging Employment Sectors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128493
Enrollment
Unknown
Registered
2026-07-21
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subclinical cardiovascular impairment

Interventions

Experimental Group:Take probiotic capsules

Sponsors

Beijing Prevention and Treatment Hospital of Occupational Disease(Beijing Institute of Occupational Disease Prevention and Treatment)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Has been working full-time as a designated driver for over 6 consecutive months, is currently still in this job, and has no other part-time work; 2. Male, aged between 30 and 45; 3. Night shift work and hours: mainly night shifts (working at least 5 days a week, with at least 4 hours between 10:00 PM and 6:00 AM), weekly working hours between 40 and 55; 4. Voluntarily willing to participate in this study and able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of cardiovascular disease and risk factors (including atherosclerosis, myocardial infarction, heart failure, hypertension, high cholesterol, overweight or obesity, etc.), currently taking medications for cardiovascular disease; 2. History of major diseases in other systems (including severe digestive system, urinary system, immune system diseases, etc.); 3. Currently having digestive system problems such as diarrhea, constipation, gastric ulcer, duodenal ulcer, etc.; 4. History of using antibiotics, probiotics, or medications for digestive system diseases in the past 3 months; 5. History of smoking or drinking; 6. Any other situation judged by the researcher as unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Gut microbiota structure and metabolites;

Secondary

MeasureTime frame
Biomarkers: ET-1, heart-type fatty acid-binding protein, high-sensitivity cardiac troponin I, N-terminal pro-B-type natriuretic peptide;

Countries

China

Contacts

Public ContactTenglong Yan

Beijing Prevention and Treatment Hospital of Occupational Disease(Beijing Institute of Occupational Disease Prevention and Treatment)

Yantlyan@163.com+86 10 6259 1713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026